Invesco Nasdaq Biotechnology ETF (IBBQ) Holdings $21.53 +0.03 (+0.14%) As of 01/17/2025 03:50 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends Top 50 IBBQ HoldingsRankCompanyCurrent PriceWeightShares Held1GILDGilead Sciences$91.84+0.2%8.65%35,6052AMGNAmgen$272.11+1.0%7.98%11,6533REGNRegeneron Pharmaceuticals$681.58-1.7%7.64%4,1174VRTXVertex Pharmaceuticals$422.00+1.2%7.43%7,0415AZNAstraZeneca$66.60-0.5%3.84%22,1846ALNYAlnylam Pharmaceuticals$246.27-1.2%3.06%4,9147BIIBBiogen$140.55-0.5%2.20%5,5528ILMNIllumina$136.67-0.5%2.13%6,0429ARGXargenx$640.52-2.9%2.01%1,22810UTHRUnited Therapeutics$358.93-2.0%1.61%1,701 Get the Latest News and Ratings for IBBQ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. 11MRNAModerna$34.06+0.9%1.52%14,66112VTRSViatris$11.30-0.4%1.49%45,47313SNYSanofi$50.741.46%11,47114NBIXNeurocrine Biosciences$143.26+0.9%1.40%3,85715INCYIncyte$71.93-0.7%1.33%7,34016SMMTSummit Therapeutics$19.03+4.6%1.33%28,09517BMRNBioMarin Pharmaceutical$61.53+0.5%1.26%7,26118INSMInsmed$72.51-0.3%1.24%6,81619SRPTSarepta Therapeutics$118.00+0.8%1.16%3,63920RPRXRoyalty Pharma$30.75-0.6%1.13%16,92721BNTXBioNTech$111.93-0.7%1.11%3,74022MEDPMedpace$337.35+0.2%1.04%1,18423PCVXVaxcyte$85.30-2.9%1.03%4,74824EXELExelixis$36.20-1.0%0.97%10,88025ITCIIntra-Cellular Therapies$126.200.0%0.89%4,03926ROIVRoivant Sciences$11.15+2.4%0.84%27,73327ASNDAscendis Pharma A/S$128.13-2.7%0.83%2,29828BeiGene, Ltd.N/A0.82%1,68929JAZZJazz Pharmaceuticals$121.18-1.2%0.75%2,30330RVMDRevolution Medicines$40.29+1.0%0.73%6,40931MDGLMadrigal Pharmaceuticals$293.64+7.6%0.68%83132HALOHalozyme Therapeutics$54.80-1.0%0.61%4,84733CYTKCytokinetics$45.74-2.7%0.56%4,49634BPMCBlueprint Medicines$110.05+5.9%0.55%2,42035IONSIonis Pharmaceuticals$31.43-2.6%0.55%6,01636BBIOBridgeBio Pharma$33.79-0.9%0.52%7,20037TEMTempus AI$35.15+1.2%0.52%5,80638NUVLNuvalent$75.84-0.2%0.51%2,48639ALKSAlkermes$29.47-0.9%0.47%6,16440CRNXCrinetics Pharmaceuticals$37.35+2.4%0.47%3,533Vladimir Lenin was right… (Ad)The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.Including the name of the #1 company to buy.41KRYSKrystal Biotech$148.39+2.5%0.46%1,09642ACLXArcellx$66.48-0.8%0.43%2,06043ADMAADMA Biologics$16.02-3.7%0.42%9,00644AXSMAxsome Therapeutics$91.93-1.9%0.41%1,84645APLSApellis Pharmaceuticals$29.93+0.7%0.40%4,73946SRRKScholar Rock$43.13-1.8%0.40%3,56747RAREUltragenyx Pharmaceutical$40.00-2.1%0.39%3,51848GHGuardant Health$36.66-1.7%0.38%4,70749PTCTPTC Therapeutics$43.84+1.8%0.36%2,93850IMVTImmunovant$23.86+0.3%0.35%5,592 Geographic ExposureUnited States95.0%Ireland1.4%Bermuda0.8%Canada0.6%Netherlands0.6%Switzerland0.4%Luxembourg0.4%Jersey0.3%United Kingdom0.2%Singapore0.2%Cayman Islands0.1%Currency ExposureUSD87.2%Sector ExposureHealth Care79.1%Consumer Discretionary0.9%Energy0.2%Industrials0.1%Industry ExposureBiotechnology72.5%Health Care Equipment & Supplies3.2%Diversified Consumer Services1.5%Pharmaceuticals1.0%Distributors0.4%Renewable Energy0.2%Commercial Services & Supplies0.1%SubIndustry ExposureBiotechnology69.1%Life Sciences Tools & Services3.8%Pharmaceuticals1.9%Health Care Equipment0.3%Renewable Energy Equipment0.2%Health Care Supplies0.1% Related Companies and Tools Related Companies LFSC Portfolio Companies MEDX Portfolio Companies FTXH Portfolio Companies BIB Portfolio Companies JDOC Portfolio Companies BIS Portfolio Companies PTH Portfolio Companies PSCH Portfolio Companies BBH Portfolio Companies PPH Portfolio Companies This page (NASDAQ:IBBQ) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
